Moderate to severe TBI is associated with elevated malignant brain tumor risk
1. In this retrospective cohort study, moderate to severe traumatic brain injury (TBI) was associated with an increased risk of ...
Tag: #cancer
AstraZeneca: Truqap improved radiographic progression-free survival in patients with metastatic prostate cancer
The addition of Truqap to standard-of-care therapy improved radiographic progression-free survival in patients with metastatic prostate cancer and loss of ...
Novocure: Wearable Electric Therapy Increases Survival in Patients with Pancreatic Adenocarcinoma
Tumor Treating Fields therapy demonstrates increased overall survival in patients with unresectable pancreatic cancer. The novel therapy was safe and ...
Machine learning algorithm shows limited capacity for reducing health spending for radiation therapy outpatients
1. Natesan and colleagues conducted a post hoc economic analysis of a trial that identified cancer patients at high risk ...
Astellas: Vyloy improves survival in patients with advanced gastric cancer
Vyloy plus standard-of-care chemotherapy extended overall survival in patients with advanced gastric cancer. The rate of grade 3 or higher ...
Sanofi’s Sarclisa approved as first-line for transplant-ineligible multiple myeloma patients
Sarclisa in combination with the VRd regiment was superior to VRd alone in improving survival in stem cell transplant ineligible ...
AbbVie’s novel epkinly results in meaningful treatment response in patients with treatment-refractory lymphoma
Epkinly showed an overall response rate of 82% with 62.5% of patients achieving complete response. 65% of patients had grade ...
Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor therapy for synovial sarcoma
Afami-cel (Tecelra) is the first genetically engineered T-cell receptor therapy for synovial sarcoma Afami-cel demonstrated an overall response rate of ...
Machine learning algorithm demonstrates ability to appropriately identify cancer patients for serious illness conversations
1. Patel and colleagues conducted a secondary economic analysis of a trial that assigned high-risk cancer patients to serious illness ...
The Scan by 2 Minute Medicine®: Tremendous Blood Tests, Protecting Against HIV, Skin Cancer Scare and Health at the Olympics:
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. ...
